Exploring the potential mechanism of qi-shen-di-huang drug formulary for myasthenia gravis (mg) based on uhplc-qe-ms network pharmacology and molecular docking techniques

HIGHLIGHTS

SUMMARY

Myasthenia gravis (MG) is an autoimmune disease with lesions in the postsynaptic membrane of the neuromuscular junction (NMJ). Binding energy and amp;lt; -4.25 kcal/mol indicates some binding activity between the small ligand molecule and the receptor protein, binding_energy and amp;lt; -5.0 kcal/mol indicates good binding activity between the two, and binding_energy and amp;lt; -7.0 kcal/mol indicates that the ligand has binding activity with the receptor binding solid activity. Epigallocatechin-3-gallate formed hydrogen_bonds with five amino_acids, ASP-46, GLU-40, LYS-39, ALA-50, and . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.